Alicia Marie Quesnel, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otosclerosis | 13 | 2022 | 113 | 6.120 |
Why?
|
| Temporal Bone | 17 | 2022 | 671 | 4.300 |
Why?
|
| Cochlear Implants | 8 | 2022 | 301 | 2.220 |
Why?
|
| Cochlear Implantation | 7 | 2022 | 279 | 2.150 |
Why?
|
| Hearing Loss, Sensorineural | 7 | 2022 | 772 | 1.790 |
Why?
|
| Stapes Surgery | 5 | 2020 | 61 | 1.670 |
Why?
|
| Aerosols | 3 | 2021 | 680 | 1.440 |
Why?
|
| Otologic Surgical Procedures | 2 | 2021 | 148 | 1.420 |
Why?
|
| Stapes | 3 | 2021 | 84 | 1.200 |
Why?
|
| Ear, Inner | 5 | 2022 | 401 | 1.190 |
Why?
|
| Hearing Loss | 4 | 2022 | 722 | 1.110 |
Why?
|
| Skull Neoplasms | 2 | 2018 | 173 | 1.030 |
Why?
|
| Diverticulum | 2 | 2022 | 133 | 1.010 |
Why?
|
| Mastoid | 2 | 2020 | 103 | 0.970 |
Why?
|
| Cochlea | 7 | 2022 | 778 | 0.840 |
Why?
|
| Hearing | 4 | 2022 | 437 | 0.830 |
Why?
|
| Deafness | 2 | 2022 | 436 | 0.820 |
Why?
|
| Facial Paralysis | 2 | 2018 | 326 | 0.790 |
Why?
|
| Hearing Loss, Conductive | 3 | 2020 | 164 | 0.780 |
Why?
|
| Endolymphatic Hydrops | 2 | 2016 | 30 | 0.760 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 137 | 0.750 |
Why?
|
| Endoscopy | 3 | 2021 | 1756 | 0.700 |
Why?
|
| Ear Diseases | 1 | 2020 | 178 | 0.680 |
Why?
|
| Vestibular Diseases | 1 | 2021 | 218 | 0.680 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2018 | 138 | 0.640 |
Why?
|
| Neurilemmoma | 2 | 2020 | 524 | 0.610 |
Why?
|
| Hemangiosarcoma | 1 | 2018 | 222 | 0.610 |
Why?
|
| Otolaryngology | 2 | 2021 | 663 | 0.600 |
Why?
|
| Otitis Media | 1 | 2018 | 281 | 0.590 |
Why?
|
| Neuroma, Acoustic | 3 | 2020 | 439 | 0.590 |
Why?
|
| Foreign-Body Reaction | 1 | 2017 | 160 | 0.590 |
Why?
|
| Acrocephalosyndactylia | 1 | 2016 | 86 | 0.560 |
Why?
|
| Laryngoscopy | 3 | 2011 | 719 | 0.530 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2015 | 96 | 0.530 |
Why?
|
| Hyperacusis | 1 | 2014 | 28 | 0.530 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2014 | 50 | 0.530 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 541 | 0.520 |
Why?
|
| Explosions | 1 | 2014 | 94 | 0.510 |
Why?
|
| Medical Futility | 1 | 2015 | 128 | 0.490 |
Why?
|
| Quadriplegia | 1 | 2015 | 186 | 0.490 |
Why?
|
| Tinnitus | 1 | 2014 | 166 | 0.460 |
Why?
|
| Osteoma | 1 | 2011 | 13 | 0.420 |
Why?
|
| Blast Injuries | 1 | 2014 | 274 | 0.420 |
Why?
|
| Diphosphonates | 2 | 2015 | 630 | 0.410 |
Why?
|
| Auditory Perception | 1 | 2015 | 515 | 0.410 |
Why?
|
| Petrous Bone | 2 | 2022 | 87 | 0.400 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1771 | 0.380 |
Why?
|
| Speech Perception | 3 | 2022 | 442 | 0.360 |
Why?
|
| Laryngostenosis | 1 | 2011 | 159 | 0.350 |
Why?
|
| Cadaver | 3 | 2020 | 1362 | 0.330 |
Why?
|
| Parotid Neoplasms | 1 | 2009 | 162 | 0.320 |
Why?
|
| Voice Quality | 1 | 2009 | 223 | 0.320 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 967 | 0.300 |
Why?
|
| Skull | 1 | 2011 | 814 | 0.290 |
Why?
|
| Electrodes, Implanted | 2 | 2022 | 785 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2022 | 20357 | 0.280 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3163 | 0.270 |
Why?
|
| Larynx | 1 | 2009 | 468 | 0.270 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3280 | 0.270 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 785 | 0.270 |
Why?
|
| Pandemics | 3 | 2021 | 7313 | 0.260 |
Why?
|
| Bone Conduction | 2 | 2016 | 103 | 0.250 |
Why?
|
| Audiometry, Pure-Tone | 2 | 2016 | 210 | 0.250 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 2473 | 0.250 |
Why?
|
| Humans | 48 | 2022 | 715818 | 0.250 |
Why?
|
| Round Window, Ear | 1 | 2022 | 40 | 0.230 |
Why?
|
| Osteogenesis | 2 | 2022 | 1276 | 0.220 |
Why?
|
| Bionics | 2 | 2022 | 35 | 0.220 |
Why?
|
| Hearing Tests | 3 | 2022 | 130 | 0.220 |
Why?
|
| Carrier Proteins | 1 | 2015 | 5101 | 0.210 |
Why?
|
| Synostosis | 1 | 2021 | 39 | 0.210 |
Why?
|
| Hearing Loss, Sudden | 1 | 2022 | 58 | 0.210 |
Why?
|
| Foot Deformities, Congenital | 1 | 2021 | 59 | 0.210 |
Why?
|
| Radiography | 4 | 2013 | 6980 | 0.210 |
Why?
|
| Reflex, Abnormal | 1 | 2021 | 85 | 0.200 |
Why?
|
| Reflex, Vestibulo-Ocular | 1 | 2021 | 84 | 0.200 |
Why?
|
| Hand Deformities, Congenital | 1 | 2021 | 147 | 0.190 |
Why?
|
| Cautery | 1 | 2020 | 60 | 0.190 |
Why?
|
| Fluorescein | 1 | 2020 | 175 | 0.190 |
Why?
|
| Audiometry | 2 | 2019 | 254 | 0.180 |
Why?
|
| Suction | 1 | 2020 | 261 | 0.180 |
Why?
|
| Fibrosis | 2 | 2022 | 1928 | 0.170 |
Why?
|
| Nasopharynx | 1 | 2020 | 388 | 0.160 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 267 | 0.160 |
Why?
|
| Male | 23 | 2022 | 350352 | 0.160 |
Why?
|
| Basilar Membrane | 1 | 2017 | 49 | 0.160 |
Why?
|
| Imidazoles | 2 | 2015 | 1249 | 0.160 |
Why?
|
| Fatal Outcome | 2 | 2019 | 1879 | 0.150 |
Why?
|
| Vestibular Aqueduct | 1 | 2017 | 61 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 320 | 0.150 |
Why?
|
| Operating Rooms | 2 | 2020 | 806 | 0.150 |
Why?
|
| Stapes Mobilization | 1 | 2016 | 8 | 0.150 |
Why?
|
| Radiosurgery | 2 | 2018 | 1349 | 0.140 |
Why?
|
| Adult | 16 | 2022 | 212279 | 0.140 |
Why?
|
| Community Health Nursing | 1 | 1995 | 24 | 0.140 |
Why?
|
| Microscopy | 1 | 2020 | 862 | 0.140 |
Why?
|
| Aged | 9 | 2022 | 162468 | 0.130 |
Why?
|
| Tympanoplasty | 1 | 2014 | 80 | 0.130 |
Why?
|
| Retrospective Studies | 10 | 2022 | 72473 | 0.130 |
Why?
|
| Vaccines | 1 | 2022 | 738 | 0.120 |
Why?
|
| Occupational Health | 1 | 2020 | 838 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 1997 | 919 | 0.120 |
Why?
|
| France | 1 | 2015 | 496 | 0.120 |
Why?
|
| Immunity, Mucosal | 1 | 1997 | 485 | 0.120 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 588 | 0.120 |
Why?
|
| Incidence | 3 | 2016 | 20733 | 0.120 |
Why?
|
| Cervix Uteri | 1 | 1997 | 578 | 0.120 |
Why?
|
| Hair Cells, Auditory | 1 | 2015 | 349 | 0.120 |
Why?
|
| Etidronic Acid | 1 | 2012 | 65 | 0.120 |
Why?
|
| Middle Aged | 11 | 2022 | 214666 | 0.110 |
Why?
|
| Vagina | 1 | 1997 | 779 | 0.110 |
Why?
|
| Neurofibromatosis 2 | 1 | 2015 | 366 | 0.110 |
Why?
|
| Comorbidity | 2 | 2020 | 10435 | 0.110 |
Why?
|
| Autopsy | 1 | 2015 | 988 | 0.110 |
Why?
|
| Nurse Practitioners | 1 | 1995 | 270 | 0.110 |
Why?
|
| Radiotherapy Dosage | 1 | 2018 | 2947 | 0.110 |
Why?
|
| Auditory Threshold | 1 | 2012 | 348 | 0.100 |
Why?
|
| Female | 17 | 2022 | 377229 | 0.100 |
Why?
|
| Vascular Malformations | 1 | 2016 | 419 | 0.100 |
Why?
|
| Laryngoplasty | 1 | 2011 | 52 | 0.100 |
Why?
|
| Ear, Middle | 1 | 2013 | 329 | 0.100 |
Why?
|
| Tracheostomy | 2 | 2011 | 401 | 0.100 |
Why?
|
| Hyperostosis, Diffuse Idiopathic Skeletal | 1 | 2009 | 24 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 1842 | 0.090 |
Why?
|
| Dilatation | 1 | 2011 | 265 | 0.090 |
Why?
|
| Syndrome | 1 | 2015 | 3193 | 0.090 |
Why?
|
| Glottis | 1 | 2011 | 239 | 0.090 |
Why?
|
| Algorithms | 1 | 2009 | 13758 | 0.090 |
Why?
|
| Prosthesis Design | 1 | 2015 | 2107 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2018 | 2929 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2011 | 451 | 0.080 |
Why?
|
| Reoperation | 2 | 2022 | 4177 | 0.080 |
Why?
|
| Semicircular Canals | 2 | 2020 | 195 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 58326 | 0.080 |
Why?
|
| Adolescent | 8 | 2019 | 85157 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 34430 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2015 | 62040 | 0.070 |
Why?
|
| Microsurgery | 1 | 2011 | 811 | 0.070 |
Why?
|
| Delayed Diagnosis | 1 | 2009 | 415 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2021 | 4630 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2011 | 2677 | 0.070 |
Why?
|
| Airway Obstruction | 1 | 2009 | 649 | 0.060 |
Why?
|
| Patient Preference | 1 | 2011 | 867 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 574 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19537 | 0.060 |
Why?
|
| Laser Therapy | 1 | 2011 | 1070 | 0.060 |
Why?
|
| Age Factors | 2 | 2011 | 18787 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 4273 | 0.060 |
Why?
|
| Biopsy | 1 | 2015 | 6737 | 0.060 |
Why?
|
| Infant | 4 | 2017 | 34569 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2009 | 962 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3451 | 0.050 |
Why?
|
| Carpal Bones | 1 | 2021 | 75 | 0.050 |
Why?
|
| Length of Stay | 1 | 2015 | 6270 | 0.050 |
Why?
|
| Tarsal Bones | 1 | 2021 | 62 | 0.050 |
Why?
|
| Young Adult | 4 | 2019 | 56228 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2014 | 40032 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 9004 | 0.050 |
Why?
|
| Disease Progression | 1 | 2016 | 13215 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2014 | 51317 | 0.050 |
Why?
|
| Child | 4 | 2017 | 74468 | 0.040 |
Why?
|
| Recurrence | 1 | 2011 | 8240 | 0.040 |
Why?
|
| Quality of Life | 2 | 2020 | 11722 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2019 | 546 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 744 | 0.040 |
Why?
|
| Carcinoma | 1 | 2009 | 2320 | 0.040 |
Why?
|
| Disposable Equipment | 1 | 1997 | 40 | 0.040 |
Why?
|
| Scala Vestibuli | 1 | 2016 | 12 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 29007 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2009 | 2415 | 0.040 |
Why?
|
| Sex Factors | 1 | 2011 | 10666 | 0.040 |
Why?
|
| Spiral Ganglion | 1 | 2017 | 168 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2017 | 41198 | 0.040 |
Why?
|
| Vestibular Nerve | 1 | 2015 | 102 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1373 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2020 | 23476 | 0.030 |
Why?
|
| Professional Autonomy | 1 | 1995 | 181 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2015 | 1421 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15102 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 23437 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2011 | 24796 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 2676 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 29290 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 2938 | 0.020 |
Why?
|
| Reference Values | 1 | 2017 | 5050 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3947 | 0.020 |
Why?
|
| Particulate Matter | 1 | 2020 | 2281 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39305 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 70879 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2009 | 560 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5742 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4029 | 0.020 |
Why?
|
| Prevalence | 1 | 2020 | 14912 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7446 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15911 | 0.010 |
Why?
|
| United States | 1 | 2020 | 67910 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 169404 | 0.000 |
Why?
|